| Literature DB >> 34585835 |
Matej Žabka1, Lavakumar Naviri1, Ruth M Gschwind1.
Abstract
The weak noncovalent interactions and flexibility of ligands play a key role in enantioselective metal-catalyzed reactions. In transition metal complexes and their catalytic applications, the experimental assessment and the design of key interactions is as difficult as the prediction of the enantioselectivities, especially for flexible, privileged ligands such as chiral phosphoramidites. Therefore, the interligand interactions in cis-PdII L2 Cl2 phosphoramidite complexes were investigated by NMR spectroscopy and computations. We were able to induce a strong conformational preference by breaking the symmetry of the C2 -symmetric side chain of one of the ligands, and shift the equilibrium between hetero- and homocomplexes towards heterocomplexes because of interligand interactions in the cis-complexes. The modulation of aryl substituents was exploited, along with the solvent effect. The combined CH-π and π-π interactions reveal design patterns for binding and folding of chiral ligands and catalysts.Entities:
Keywords: NMR spectroscopy; conformational analysis; noncovalent interactions; phosphoramidites; supramolecular balance
Year: 2021 PMID: 34585835 PMCID: PMC9298319 DOI: 10.1002/anie.202106881
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 16.823
Figure 1a) cis‐PdII bis(phosphoramidite) complexes as model system for interligand interactions. b) Supramolecular balance: experimental access to the interaction difference between two diastereomeric heterocomplexes using the ligand combination A, A′, and F; for details see ref. [32]. c) Structures of the ligands used in the homo‐ and heterocomplex equilibria including alkyl group structural variations of the biphenyl phosphoramidite ligands A and A′. d) Tight interligand interactions in the cis‐complexes manifested by significant chemical shift changes in the 1H NMR spectra of trans‐ and cis‐Pd(E)(F)Cl2, as well as a large chemical shift dispersion in cis‐Pd(E)(F)Cl2 (CD2Cl2, 300 K).
Preference of heterocomplex formation upon alkyl group variation in ligand A or A′ (matched and mismatched regarding F). Given are the cis‐Pd(E)(F)Cl2/cis‐Pd(E)2Cl2/cis‐Pd(F)2Cl2 ratios.[a]
|
Ligand X |
(X)( |
Ligand X |
(X)( |
|---|---|---|---|
|
|
2.2:1.0:1.1 |
|
3.5:1.0:1.0 |
|
|
4.4:1.0:0.9 |
|
3.2:0.9:1.0 |
|
(Naphth(Me)CH) |
2.3:1.0:1.0 |
|
8.0:1.0:1.0 |
|
(Naphth(Me)CH) |
1.6:1.0:1.1 |
|
22.0:0.9:1.0 |
|
|
1.0:1.0:1.0 |
|
3.0:1.2:1.0 |
|
|
1.2:1.0:0.7 |
|
6.2:1.0:1.0 |
|
|
1.7:1.0:1.0 |
|
3.0:0.6:1.0 |
|
|
|
|
15.0:0.6:1.0 |
[a] Ratio determined by 31P{1H} NMR, CD2Cl2, 300 K.
Figure 2a) Structures of the homocomplexes and the heterocomplex cis‐Pd(E)(F)Cl2 in CD2Cl2, the interligand interaction areas are highlighted. The preferred formation of the heterocomplex is reproduced by calculations in terms of ΔG solv (B2PLYP/CBS(TQ)/SMD(CH2Cl2)//PBE‐D3(BJ)/def2‐SVP/CPCM(CH2Cl2). b) 1D and 2D NOESY data reveal a close proximity of the Ph(Me)CH group and the binaphthyl core and define interligand interactions. c) Key interaction area in the stabilized heterocomplexes with functional features for its preference. Dispersion interaction density plot (DLPNO‐CCSD(T)/def2‐TZVP) shows a major role of dispersion in the interactions. d) NCI plots of cis‐Pd(E)(F)Cl2 and cis‐Pd(E′)(F)Cl2 showing a larger, continuous dispersion area in the mismatched complex.
Figure 3a) Equilibrium between the hetero‐ and homocomplexes; ligand structures with the electronic and steric variations of the ligand aryl substituent. b) Interligand interaction areas in the matched and mismatched ligand combinations. Higher preference for the heterocomplex in the mismatched case is due to stronger aromatic interactions.
Equilibrium complex ratios in CD2Cl2 upon ligand aryl group variations.
|
Ligand
|
(X)( (matched) |
(X′)( (mismatched) |
ΔΔ [kJ mol−1]
|
|---|---|---|---|
|
|
8.0:1.0:1.0 |
22.0:0.9:1.0 |
5.3 |
|
12.0:1.0:1.0 |
64.0:1.0:1.0[d] |
8.4 | |
|
|
11.6:1.5:1.0 |
29.0:1.0:1.0[b] |
5.6 |
|
|
11.0:1.0:0.8 |
3.0:1.0:1.2 |
−7.5 |
|
|
6.0:1.0:1.0 |
21.0:1.0:1.0 |
6.3 |
|
|
6.3:1.0:1.0 |
16.0:1.0:1.0 |
4.7 |
|
|
6.8:1.0:1.0 |
broad peaks |
– |
[a] Ratio determined by 31P{1H} NMR (151 MHz), CD2Cl2, 300 K. [b] Other (E)2 homocomplexes were present. [c] ΔΔG was calculated as the difference between ΔG of the matched and mismatched equilibrium, assuming that the concentration of cis‐Pd(X)2Cl2 is equal to cis‐Pd(F)2Cl2, irrespective of other X homocomplexes present. [d] In CDCl3.